This list is an analysis based on recent market events. It's not an investment recommendation.
About
NextCell Pharma AB operates as a biopharmaceutical enterprise, dedicating its efforts to the groundbreaking research and advancement of novel stem cell-based therapies within Sweden. A significant development from the company is ProTrans, an investigational drug derived from stem cells, primarily formulated to address autoimmune and inflammatory ailments. Beyond therapeutic development, NextCell Pharma AB also offers Cellaviva, a specialized stem cell banking service that enables families to securely preserve stem cells sourced from umbilical cord blood and tissue. Established in 2014, the company maintains its corporate headquarters in Huddinge, Sweden.
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange NextCell Pharma AB stocks are traded under the ticker NXTCL-BT-UN.ST.
When is the next NextCell Pharma AB earnings date?▼
NextCell Pharma AB is going to release the next earnings report on October 22, 2026.
What is NextCell Pharma AB revenue for the last year?▼
NextCell Pharma AB revenue for the last year amounts to 19.28M SEK.
What is NextCell Pharma AB net income for the last year?▼
NXTCL-BT-UN.ST net income for the last year is -61.65M SEK.
How many employees does NextCell Pharma AB have?▼
As of September 04, 2026, the company has 24 employees.
In which sector is NextCell Pharma AB located?▼
NextCell Pharma AB operates in the Health & Wellness sector.
When did NextCell Pharma AB complete a stock split?▼
NextCell Pharma AB has not had any recent stock splits.
Where is NextCell Pharma AB headquartered?▼
NextCell Pharma AB is headquartered in Huddinge, Sweden.